Relationship between rheumatoid arthritis and Mycoplasma pneumoniae: A case-control study

Rheumatology

Volumn 44, Issue 7, 2005, Pages 912-914

  Ramirez A S ^a   Rosas, A ^a   Hernandez Beriain J A ^b   Orengo, J C ^b   Saavedra, P ^a   de la Fe, C ^a   Fernandez A ^a   Poveda, J B ^a  

^a UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^b HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

Author keywords

Case control studies; ELISA; Mollicutes; Mycoplasma pneumoniae; Rheumatoid arthritis

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G;

ADULT; AGE; AGED; ARTICLE; BLOOD ANALYSIS; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENDER; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MYCOPLASMA PNEUMONIAE; NONHUMAN; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; WORK; BLOOD; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED; MYCOPLASMA PNEUMONIA;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA;

EID: 22844446158     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keh630     Document Type: Article

References (28)

1. Andreu Sánchez JL, Barceló García P, Figueroa Pedrosa M et al. Manual de enfermedades reumáticas de la Sociedad Española de Reumatología. Barcelona: Mosby/Doyma Libros, 1996.
2. Hernández LA, Urquhart GED, Dick WC. Mycoplasma pneumoniae infection and arthritis in man. Br Med J 1977;2:14-16.
3. Taylor-Robinson D. Mycoplasmal arthritis in man. Isr J Med Sci 1981;17:616-21.
4. Taylor-Robinson D, Gumpel JM, Hill A, Swannell AJ. Isolation of Mycoplasma pneumoniae from the synovial fluid of a hypogamma-globulinaemic patient in a survey of patients with inflammatory polyarthritis. Ann Rheum Dis 1978:37:180-2.
5. Taylor-Robinson D, Gilroy CB, Horowitz S, Horowitz J. Mycoplasma genitalium in the joints of two patients with arthritis. Eur J Clin Microbiol Infect Dis 1994:13:1066-9.
6. Burdge DR, Reid GD, Reeve CE, Robertson JA, Stemke GW, Bowie WR. Septic arthritis due to dual infection with Mycoplasma hominis and Ureaplasma urealyticum. J Rheumatol 1988;15:366-8.
7. Von Recklinghausen G. Use of microbiologic-serologic studies for Chlamydia and Mycoplasma in differential diagnosis of inflammatory rheumatic diseases. Z Rheumatol 1990;49:361-3.
8. Barile MF, Kapatais-Zoumbos K, Snoy PJ et al. Experimentally induced septic arthritis in chimpanzees infected with Mycoplasma hominis, Mycoplasma pneumoniae and Ureaplasma urealyticum. Clin Infect Dis 1994;18:694-703.
9. Furr PM, Taylor-Robinson D, Webster ADB. Mycoplasmas and ureaplasmas in patients with hypogammaglobulinemia and their role in arthritis: microbiological observation over twenty years. Ann Rheum Dis 1994:53:183-7.
10. Tully JG, Rose DL, Baseman JB, Dallo SF, Lazzell AL, Davis CP. Mycoplasma pneumoniae and Mycoplasma genitalium mixture in synovial fluid isolate. J Clin Microbiol 1995:33:1851-5.
11. Franz A, Webster ADB, Furr PM, Taylor-Robinson D. Mycoplasmal arthritis in patients with immunoglobulin deficiency: Clinical features and outcome in 18 patients. Br J Rheumatol 1997:36:661-8.
12. Schaeverbeke T, Renaudin H, Clerc M et al. Systematic detection of mycoplasmas by culture and polymerase chain reaction (PCR) procedures in 209 synovial fluid samples. Br J Rheumatol 1997; 36:310-14.
13. Poggio TV, Orlando N, Galanternik L, Grinstein S. Microbiology of acute arthropathies among children in Argentina: Mycoplasma. Pediatr Infect Dis J 1998;17:304-8.
14. Schaeverbeke T, Gilroy CB, Bebear C, Dehais J, Taylor-Robinson D. Mycoplasma fermentans, but not M. penetrans, detected by PCR assays in synovium from patients with rheumatoid arthritis and other rheumatic disorders. J Clin Pathol 1996;49:824-8.
15. Haier J, Nasralla M, Franco AR, Nicolson GL. Detection of mycoplasmal infections in blood of patients with rheumatoid arthritis. Rheumatology 1999;38:504-9.
16. Horowitz S, Evinson B, Borer A, Horowitz J. Mycoplasma fermentans in rheumatoid arthritis and other inflammatory arthritides. J Rheumatol 2000:27:2747-53.
17. Johnson S, Sidebottom D, Bruckner F, Collins D. Identification of Mycoplasma fermentans in synovial fluid samples from arthritis patients with inflammatory disease. J Clin Microbiol 2000:38:90-3.
18. Gilroy CB, Keat A, Taylor-Robinson D. The prevalence of Mycoplasma fermentans in patients with inflammatory arthritides. Rheumatology 2001;40:1355-8.
19. Jansson E, Backman A, Hakkarainen K, Miettinen A, Seniusova B. Mycoplasmas and arthritis. Z Rheumatol 1983;42:315-19.
20. Baseman JB, Tully JG. Mycoplasmas: Sophisticated, re-emerging, and burdened by their notoriety. Emerg Infect Dis 1997;3:21-32.
21. Van der Heijden IM, Wilbrink B, Tchetverikov I et al. Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arthritis Rheum 2000; 43:593-8.
22. Davis CP, Cochran S, Lisse J et al. Isolation of Mycoplasma pneumoniae from synovial fluid samples in a patient with pneumonia and polyarthritis. Arch Intern Med 1988;148:969-70.
23. Aho K, Heliövaara M, Knekt P et al. Serum immunoglobulins and the risk of rheumatoid arthritis. Ann Rheum Dis 1997;56:351-6.
24. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988:31:315-24.
25. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc 1949;140:659-65.
26. Hosmer DW, Lemeshow S. Logistic regression for matched case-control studies. In: Cressic NAC, Fisher NI, Johnstone IM et al., eds. Applied logistic regression, 2nd edn. New York: John Wiley, 2000: 223-59.
27. Cole BC, Griffith, MM. Triggering and exacerbation of autoimmune arthritis by the Mycoplasma arthritidis superantigen MAM. Arthritis Rheum 1993:36:994-1002.
28. Tilley BC, Alarcon GS, Heyse SP et al. Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group. Ann Intern Med 1995;122:81-9.